Indications of quinolone antibiotics restricted following EU-wide safety review
New restrictions and precautions for use have been implemented for quinolone antibiotics following very rare reports of disabling, long-lasting or potentially irreversible adverse reactions affecting the musculoskeletal and nervous systems.
by Lisa Lytle
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.